ED

Eric Dai

Investor @ Dimension | Life Sciences and Technology

San Francisco, California

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $40,000,000.00
  • Target Investment:

    $20,000,000.00

Work Experience

2023

  • Investor

    2023

    Investing in founders pushing the frontier of tech and life sciences. Learn more at: https://www.dimensioncap.com

2022 - 2023

  • Bio+Health Deal Analyst

    2022 - 2023

    a16z Bio Fund IV $1.5B Vehicle for Early and Growth Stage Bio+Health Startups

  • PhD Student in Bioengineering, Mauck Lab

    2016 - 2022

    (On Leave) Stem Cell Mechanobiology/Engineering with Rob Mauck

  • Teaching Assistant

    2018 - 2021

    TA for MSE 496 Senior Design with Vanessa Chan TA for BE 306 Cellular Engineering with Daniel Hammer

2021 - 2022

  • Venture Associate

    2021 - 2022

    Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Created by the leaders behind iconic companies like Twist Bioscience, Ginkgo Bioworks, Beyond Meat, Exact Sciences, and many more.

  • Program Coordinator at the DOE Office of Technology Transitions

    2021 - 2022

    Cleantech Commercialization

2021 - 2022

  • Biotech Correspondent

    2021 - 2022

    Reported on leading startups in mRNA engineering, nucleic acid delivery and more

2021 - 2021

  • Co-Founder, Co-Managing Director

    2021 - 2021

    Bio Launch supports venture formation from biotechnologies at the University of Pennsylvania, the Wistar Institute, and CHOP. Merged into Nucleate to form Nucleate Philadelphia.

2020 - 2021

  • Head of Content & Community

    2020 - 2021

    Podcast, Articles, Community Engagement

2020 - 2021

  • Venture Fellow

    2020 - 2021

    Seed Stage Biotech VC

  • Campus Ambassador

    2020 - 2020

  • Research Assistant

    2011 - 2012

    Particle Physics